title: Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?
authors.affiliation: Clinical Virology Laboratory, Hospices Civils de Lyon, Lyon, France; Centre International de Recherche en Infectiologie, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, Lyon, France; Lyon University, Villeurbanne, France.
authors.forename: Caroline
authors.initials: C
authors.lastname: Scholtès
authors.affiliation: Lyon University, Villeurbanne, France; Cancer Research Center of Lyon, INSERM U1052, CNRS 5286, Lyon, France.
authors.forename: Rajneesh
authors.initials: R
authors.lastname: Kumar
authors.affiliation: Lyon University, Villeurbanne, France; Hepatology Department, Hospices Civils de Lyon, Lyon, France; Cancer Research Center of Lyon, INSERM U1052, CNRS 5286, Lyon, France.
authors.forename: Fabien
authors.initials: F
authors.lastname: Zoulim
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019701:Hepatitis D, Chronic / Q000188:drug therapy*; D003698:Hepatitis Delta Virus / Q000302:isolation & purification*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood*; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012367:RNA, Viral; D011092:Polyethylene Glycols